Clinical Trials Landscape in Mexico

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials Landscape in Mexico

Clinical Trials Landscape in Mexico – Top CRO Companies

Clinical trials play a vital role in advancing medical knowledge and improving patient care. In recent years, Mexico has emerged as a prominent destination for clinical research, offering a rich landscape for conducting trials.

This blog post delves into the clinical trials landscape in Mexico, highlighting its potential, challenges, regulatory framework, and recent developments. By understanding Mexico’s unique advantages and opportunities, we can gain insights into the country’s contributions to medical research and its potential for future breakthroughs.

Overview of Mexico’s Clinical Trials Landscape

Mexico’s clinical trials landscape has experienced significant growth in recent years, attracting both domestic and international researchers. The country offers a diverse patient population, with a range of ethnicities and disease profiles, making it an ideal location for conducting trials across various therapeutic areas.

With its large population and centralized healthcare system, Mexico provides researchers with access to a substantial pool of potential participants, accelerating the recruitment process.

Regulatory Framework and Ethical Considerations

Mexico has a well-established regulatory framework for clinical trials, governed by the Federal Commission for Protection against Health Risks (COFEPRIS). COFEPRIS ensures that trials adhere to international standards, safeguarding participant rights, and maintaining data integrity.

Ethical considerations are given high priority, with Institutional Review Boards (IRBs) overseeing the approval process. This ensures that trials are conducted ethically and in compliance with Good Clinical Practices (GCP).

Advantages of Conducting Clinical Trials in Mexico

Mexico offers several advantages that make it an attractive destination for clinical research. Firstly, its diverse patient population allows researchers to study the impact of treatments on different ethnic groups, enhancing the generalizability of study results. Moreover, Mexico’s large population size facilitates rapid patient recruitment, shortening the duration of trials and reducing costs.

Additionally, the country’s proximity to the United States enables easier collaboration between Mexican and American research institutions, fostering knowledge exchange and joint efforts in medical research.

Clinical Trials Landscape in Mexico
Clinical Trials Landscape in Mexico

Challenges and Opportunities

While Mexico presents many opportunities for clinical trials, it also faces certain challenges. One key challenge is the need for improved infrastructure and resources in some regions. Efforts are underway to address this issue by enhancing research capabilities, establishing research centers, and fostering collaborations with international organizations.

Another challenge is the need for increased public awareness and education about clinical trials to dispel misconceptions and encourage participation.

Despite these challenges, Mexico is actively working towards enhancing its clinical research landscape. The country has made notable progress in streamlining regulatory processes and improving transparency, making it an attractive destination for pharmaceutical companies and contract research organizations (CROs) looking to conduct trials efficiently and effectively.

Recent Developments and Future Outlook

Mexico’s commitment to advancing clinical research is evident in its recent developments. The government has implemented initiatives to promote research and innovation, such as tax incentives for clinical trials and the creation of specialized research centers. Moreover, collaborations with international partners have expanded, fostering knowledge transfer and promoting the exchange of expertise.

Looking ahead, Mexico’s clinical trials landscape holds immense potential. As the country continues to invest in research infrastructure, bolster regulatory mechanisms, and strengthen collaboration with global stakeholders, it is poised to become an even more prominent player in the field of clinical trials. This progress will not only contribute to medical advancements but also benefit patients in Mexico by providing access to cutting-edge treatments and therapies.


Mexico’s clinical trials landscape offers a promising environment for conducting medical research. With a diverse patient population, robust regulatory framework, and ongoing efforts to improve research infrastructure, the country presents significant opportunities for pharmaceutical companies, CROs, and researchers alike.

By capitalizing on its advantages and addressing challenges such as infrastructure development and public awareness, Mexico can further enhance its position in the global clinical trials landscape.

Clinical Trials Landscape in Mexico

Source: Roche

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Clinical Trials Landscape in Mexico

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Clinical Trials Landscape in Mexico

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Clinical Trials Landscape in Mexico

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Clinical Trials Landscape in Mexico

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Clinical Trials Landscape in Mexico

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Clinical Trials Landscape in Mexico

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Clinical Trials Landscape in Mexico

The Cohortias Team

Clinical Trials Landscape in Mexico

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Clinical Trials Landscape in Mexico

Network & Partnerships